react cso global report 2012

Engaging global CSOs

Maria Teresa Bejarano. ReAct Uppsala. 2012-11-15

Project GoalTo coordinate the three regional sub projects and to link project results to global CSOs to address ABR within child and maternal health.

SrategyReAct will link CSO partners and results to ongoing work with global CSO partners with whom ReAct is working in another project on controlled distribution of antibiotics.

Project activities

• Overall project coordination• Linkage with CSOs at global level• Arrange meetings of partner CSOs• Monitoring and Evaluation of project

Expected Results

• Outcome: the foundation for a global network of CSOs to address ABR established

• Output 1:Global CSOs informed and connected to a network of CSOs addressing ABR

• Output 2: Evidence and tools for CSO participation in ABR policy processes

Exploratory activities during 2012

Exploratory activities during 2012

• Thinking @ linking to global CSOs working with M&C health– Know local CSOs, relations with regional and global.

Stakeholders analysis

• Thinking @ linking to global CSOs working with women&child issues

• Thinking @ linking to global CSOs working with environmental issues

• Informing CSOs that approach ReAct in Uppsala• Planning CDU project

Planning activities during 2013….

• Strategy: to develop strategy with input from Cuenca meeting

• Issues to consider:• existing relationships of project CSOs with nat, reg, glob

CSOs (what are important pathways)• Which Glob CSOs are relevant in relation to focus of

projects? or might be interested • Which Glob CSOs MUST be engaged?

– Agree on a strategy

Expected activities during 2013

• Approach global CSOs inform @ local and regional activities in LA, SEA, Africa - build a relationship and discuss how ABR fits within the main focus of their work.– Guage their interest and willingness to learn more about the

methods and materials of the project

• Meeting with interested global/ CSOs

• Should there be a separate meeting of global CSOs or should this happen in conjunction with the annual project meetings? – especially the last meeting in SEA where the project results will be shown

• CDU meeting, participation of CSOs• What overlap might there be wrt CSO project and its focus?

Targetting global CSOs

• MSF• HAI• Wemos• South Center• EPN• Consumer International• TWN

CDU PROJECT

THE GLOBAL PUBLIC HEALTH THREAT OF ABR: PRESERVING ANTIBIOTICS – WHAT DO WE DO WHILE WAITING FOR NEW

DRUGS?

• Objective: provoke, support, promote, and engage global, national, and regional stakeholders to debate the controlled distribution and use of new AB leading to the initiation of a change process towards local and global systems of use that will preserve new Abs as long as possible.

CDU PROJECT

Analysis of stakeholders Debate article

Engagement of key actors High level meeting

Buy in of enough participants to take next steps towards reforms needed to preserve new ABs

PUBLIC AND PRIVATE EXPENDITURE ON HEALTH

SPENDING ON HEALTH AND PHARMACEUTICALS BY POOREST 4 BN (BOP)

Estimated Global Distribution of Counterfeit Medicine

IMS Institute for Healthcare Informatics

THE COST OF INAPROPRIATE USE OF MEDICINES

• The IMS Institute for Healthcare Informatics has identified an opportunity to save a half trillion dollars in annual global health spending through the responsible use of medicines.

ANTIBIOTIC MIS-USE REPRESENTS 11%

IMS Institute for Healthcare Informatics, 2012. This includes 186 countries.

FREQUENCY OF NON-PRESCRIPTION USE OF ANTIMICROBIALS

PPPS AND NEW BUSINESS MODELS

The drug development pipeline for antibiotics has gone dry

Towards a new business logic for R&D of novel antibiotics

• Needs driven - based on analysis of pipeline vs resistance and its burden

• Solving the scientific challenges

• Incentives that stimulate R&D of priority antibiotics

• De-linking return of investment from sales • Controlled use and distribution of new AB• special medicine?, moratorium?

•Equitable global access and affordability ?

SPECIAL REGULATORY DESIGNATIONS

Global recommendations: - International board for antibiotics within the

framework of health regulation eg: UN rapporteur for antimicrobial

resistance; similar system like controlled medicines

- Global recommendation to limit or control by regulation the level of use of new antibiotics,

Implementation of the global recommendations :

by country, should be context specific

• Why Coca Cola is readily available and why essential medicines are not

4 AS FRAMEWORK

• Acceptance: To what extent do patients accept medicines, treatment regimens and health care providers?

• Awareness: How aware is the population of health-related issues (i.e., symptoms, quality of medicines and health care providers)?

• Availability: How readily available are medicines, health in- frastructures and health care providers to local populations?

• Affordability: Can patients, health care providers, pharma- cists and institutional payers afford and finance medicines and health services?

• To realise the full potential of these 4As, a fifth A is vital: other actors, such as health-related NGOs, MFIs, governments or in- ternational organisations.

SUSTAINING LONG TERM ACTION

Tukuy shunguy yupaichani

Thank youMeda moase

GRACIASTACK